SILVERCREST ASSET MANAGEMENT GROUP LLC
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1232395
NEW YORK, NY
Position in KNSA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,993,508
+$1,490,493 QoQ
Shares Held
109,359
-4.3% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#56
of 266 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $59,241,812 across 5 Drug Manufacturers - Specialty & Generic names. KNSA ranks #3 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
270,710 | $30,032,567 | |
| 2 | PBH |
Prestige Consumer Healthcare Inc.
|
421,440 | $19,921,468 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
109,359 | $6,993,508 | |
| 4 | HLN |
Haleon plc
|
192,126 | $1,792,535 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
926 | $501,734 |
All Filings in KNSA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,993,508 | 109,359 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,503,015 | 114,289 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,214,371 | 126,409 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,902,675 | 126,260 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||